Search results
Showing 31 to 45 of 61 results for warfarin
a mean CHADs2Vasc score of 2.6, of which 11 required consideration for warfarin or similar. The prevalence of newly detected AF as a...
Evidence-based recommendations on dabigatran etexilate (Pradaxa) for preventing venous thromboembolism after hip or knee replacement surgery in adults.
be important if you have diabetes or are overweight. If you are taking warfarin, you should avoid using cranberry products. Taking...
doses to improve efficacy and reduce potential side effects. For those on Warfarin it extracts which patients have time in therapeutic...
Mant J, Hobbs FDR, Fletcher K, Roalfe A, Fitzmaurice D, Lip GYH, et al. Warfarin versus aspirin for stroke prevention in an elderly...
This quality standard covers identifying and managing atrial fibrillation (including paroxysmal, persistent and permanent atrial fibrillation, and atrial flutter) in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.
View quality statements for QS93Show all sections
Sections for QS93
- List of quality statements
- Quality statement 1: Anticoagulation to reduce stroke risk
- Quality statement 2: Use of aspirin
- Quality statement 3: Discussing options for anticoagulation
- Quality statement 4: Anticoagulation control
- Quality statement 5: Referral for specialised management
- Quality statement 6 (developmental): Self-monitoring of anticoagulation
- Update information
be important if you have diabetes or are overweight. If you are taking warfarin, you should avoid using cranberry products. Vaginal...
Bortezomib and thalidomide for the first‑line treatment of multiple myeloma (TA228)
Evidence-based recommendations on bortezomib (Velcade) and thalidomide (Thalidomide Celgene) for treating multiple myeloma in adults.
Overprescribing of rivaroxaban in non-atrial fibrillation patients in primary care
licensing of rivaroxaban and other DOACS, patients anticoagulated with warfarin would have regular, planned contact with healthcare...
per NICE guidance (Recommendation 1.11.2), with assessment of TTR with warfarin (Recommendation 1.6.9) and renal function using the...
Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events (IPG472)
Evidence-based recommendations on percutaneous closure of the patent foramen ovale for the prevention of cerebral embolic stroke. This involves placing a small device into the heart to close the hole.
Familial hypercholesterolaemia: identification and management (CG71)
This guideline covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of coronary heart disease as a result of having FH.
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158)
This guideline covers diagnosing and managing venous thromboembolic diseases in adults. It aims to support rapid diagnosis and effective treatment for people who develop deep vein thrombosis (DVT) or pulmonary embolism (PE). It also covers testing for conditions that can make a DVT or PE more likely, such as thrombophilia (a blood clotting disorder) and cancer.
administration of anticoagulants early (NICE, 2020). Vitamin K antagonists (such as Warfarin) can be started as early as the first or...
Summary of the evidence on co-enzyme Q10 for mitochondrial disorders in children to inform local NHS planning and decision-making